Researchers in China have recently proposed the study of bee venom as a potential treatment for or preventive agent against infection with SARS-CoV-2, the virus that causes the novel coronavirus disease (COVID-19).
Vitamin D, which is known to protect against acute respiratory infections, is associated with a reduced risk of infection with SARS-CoV-2, the virus that causes the coronavirus disease 2019 (COVID-19), suggests a recent study, which has yet to be peer-reviewed.
Patients who have failed initial Helicobacter pylori eradication therapy are at heightened risk of upper gastrointestinal bleeding (UGIB), with the risk increasing progressively with longer time until retreatment, according to a recent study.
Using sofosbuvir-based direct antiviral agents (DAAs) may accelerate the decline of estimated glomerular filtration rate (eGFR) in patients with chronic hepatitis C virus (HCV) infections, reports a new study.
SER-109, an investigational microbiome drug consisting of a consortium of bacterial spores from healthy donors to prevent recurrent Clostridioides difficile infection (CDI), has shown a favourable safety profile in a phase II trial. Early engraftment of SER-109 dose-species helps reduce the risk of recurrence, although engraftment kinetics suggests a higher dosing to increase efficacy.
Adjuvanted FLU-v, a broad-spectrum influenza vaccine that induces antibodies and cell-mediate immunity, has demonstrated immunogenicity in a phase IIb trial, warranting phase III development to explore its safety and efficacy.
Patients with coronavirus disease 2019 (COVID-19) pneumonia appear to exhibit potential mild pancreatic injury patterns, which may be linked to direct viral involvement of the pancreas or to secondary enzyme abnormalities in the setting of severe illness without extensive pancreatic injury, as reported in a study.
A wristwatch-like device that monitors pulse, breathing and blood oxygen levels of the user allows physicians to provide care remotely both in hospital and nontraditional settings, and may help in the fight against the coronavirus disease 2019 (COVID-19) pandemic.
The use of a vaginal cleansing intervention prior to Caesarean delivery reduced the incidence of surgical site infections (SSIs), according to a study presented at ACOG 2020. However, the addition of intravenous (IV) azithromycin prophylaxis had no added impact on SSI rates.
Persons suffering from asthma should pay particular attention to SARS-CoV-2 precautionary measures such as social distancing, regular handwashing, and wearing of masks on top of keeping their asthma in control. This is because data collected so far paints a bleaker picture for asthmatics than the normal population should they catch COVID-19.
Herd immunity will not work in the novel coronavirus disease (COVID-19), according to an infectious disease expert who addressed over 3,600 primary care physicians (PCP) from Asia Pacific at the inaugural webcast of the MIMS COVID Conversations Series.